Utah Medical Products Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $94
- Today's High:
- $95.69
- Open Price:
- $94.5
- 52W Low:
- $79.3318
- 52W High:
- $108.8126
- Prev. Close:
- $93.92
- Volume:
- 7900
Company Statistics
- Market Cap.:
- $344.67 million
- Book Value:
- 32.529
- Revenue TTM:
- $52.48 million
- Operating Margin TTM:
- 39.49%
- Gross Profit TTM:
- $32.20 million
- Profit Margin:
- 32.69%
- Return on Assets TTM:
- 10.46%
- Return on Equity TTM:
- 15.1%
Company Profile
Utah Medical Products Inc had its IPO on 1999-03-08 under the ticker symbol UTMD.
The company operates in the Healthcare sector and Medical Instruments & Supplies industry. Utah Medical Products Inc has a staff strength of 186 employees.
Stock update
Shares of Utah Medical Products Inc opened at $94.5 at the start of the last trading session i.e. 2023-06-03.
The stocks traded within a range of $94 - $95.69, and closed at $95.
This is a +1.15% increase from the previous day's closing price.
A total volume of 7,900 shares were traded at the close of the day’s session.
In the last one week, shares of Utah Medical Products Inc have increased by +1.71%.
Utah Medical Products Inc's Key Ratios
Utah Medical Products Inc has a market cap of $344.67 million, indicating a price to book ratio of 3.3571 and a price to sales ratio of 6.7357.
In the last 12-months Utah Medical Products Inc’s revenue was $52.48 million with a gross profit of $32.20 million and an EBITDA of $27.71 million. The EBITDA ratio measures Utah Medical Products Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Utah Medical Products Inc’s operating margin was 39.49% while its return on assets stood at 10.46% with a return of equity of 15.1%.
In Q1, Utah Medical Products Inc’s quarterly earnings growth was a positive 20.8% while revenue growth was a positive 1.6%.
Utah Medical Products Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 20.1271
- PEG
- 0
Its diluted EPS in the last 12-months stands at $4.72 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Utah Medical Products Inc’s profitability.
Utah Medical Products Inc stock is trading at a EV to sales ratio of 5.6961 and a EV to EBITDA ratio of 10.9092. Its price to sales ratio in the trailing 12-months stood at 6.7357.
Utah Medical Products Inc stock pays annual dividends of $1.17 per share, indicating a yield of 1.26% and a payout ratio of 24.95%.
Balance sheet and cash flow metrics
- Total Assets
- $127.77 million
- Total Liabilities
- $6.07 million
- Operating Cash Flow
- $-43000.00
- Capital Expenditure
- $43000
- Dividend Payout Ratio
- 24.95%
Utah Medical Products Inc ended 2023 with $127.77 million in total assets and $0 in total liabilities. Its intangible assets were valued at $127.77 million while shareholder equity stood at $118.02 million.
Utah Medical Products Inc ended 2023 with $638000.00 in deferred long-term liabilities, $6.07 million in other current liabilities, 36000.00 in common stock, $129.15 million in retained earnings and $13.50 million in goodwill. Its cash balance stood at $-328000.00 and cash and short-term investments were $80.91 million. The company’s total short-term debt was $0 while long-term debt stood at $0.
Utah Medical Products Inc’s total current assets stands at $95.11 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $3.82 million compared to accounts payable of $1.03 million and inventory worth $9.94 million.
In 2023, Utah Medical Products Inc's operating cash flow was $-43000.00 while its capital expenditure stood at $43000.
Comparatively, Utah Medical Products Inc paid $0.25 in dividends in 2023.
Other key metrics
- Current Trading Price
- $95
- 52-Week High
- $108.8126
- 52-Week Low
- $79.3318
- Analyst Target Price
- $
Utah Medical Products Inc stock is currently trading at $95 per share. It touched a 52-week high of $108.8126 and a 52-week low of $108.8126. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $93.94 and 200-day moving average was $91.36 The short ratio stood at 7.43 indicating a short percent outstanding of 0%.
Around 647% of the company’s stock are held by insiders while 7253.7% are held by institutions.
Frequently Asked Questions About Utah Medical Products Inc
Similar Industry Stocks (Medical Instruments & Supplies)
Most Active
Top Gainers
Top Losers
About
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO, an umbilical vessel catheters, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATHNUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation devices; suprapubic catheterization; LIBERTY, an urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women’s health centers in hospitals, outpatient clinics, and physician’s offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.